Four Compartment Method As an Efficacious and Simplified Technique for Autologous Non-cultured Epidermal Cell Suspension Preparation in Vitiligo Surgery: A Randomized, Active-controlled Study
Overview
Affiliations
Background: Autologous non-cultured epidermal cell suspension (NCES) is a successful surgical method for repigmentation of stable, refractory vitiligo. The need for laboratory equipment and expertise restricts its use to only a few research centres; hence, there is a requisite to simplify the technique of NCES preparation.
Objectives: To evaluate the efficacy of NCES prepared by four compartment (4C) method compared to the laboratory-based method (lab-NCES).
Methods: Anatomically based matched lesions (41 pairs) in 30 stable vitiligo patients were randomized to receive NCES prepared by 4C method or lab-NCES. Each patient was evaluated at 4, 8, 16 weeks after surgery by a blinded observer with regard to extent of repigmentation, colour match, patient global assessment (PGA) and pattern of repigmentation.
Results: Repigmentation outcome in 4C method as compared to lab-NCES was as follows: excellent (≥90%) repigmentation: 34% vs. 37%, P = 1.000, good (≥75%) repigmentation: 68% vs. 71%, P = 1.000; colour match: 59% vs. 54%, P = 0.794, patient satisfaction based on PGA score - 23.02 vs. 23.39 (P = 0.210) and major pattern of repigmentation (diffuse) - 76% vs. 71% (P = 0.618).
Limitations: Short follow-up period of 16 weeks.
Conclusion: Four compartment method is a simple and effective technique for vitiligo surgery in routine clinical practice.
Moftah N, Samaka R, Jamal-Edine A, Mostafa H Arch Dermatol Res. 2025; 317(1):290.
PMID: 39825923 DOI: 10.1007/s00403-024-03735-1.
Chavan C, Ray S, Kumar C Indian J Med Res. 2024; 160(5):411-427.
PMID: 39737504 PMC: 11683502. DOI: 10.25259/ijmr_2141_23.
Jafarzadeh A, Mohammad A, Goodarzi A J Cosmet Dermatol. 2024; 24(2):e16660.
PMID: 39509558 PMC: 11847760. DOI: 10.1111/jocd.16660.
Jafarzadeh A, Mohammad A, Keramati H, Zeinali R, Khosravi M, Goodarzi A Stem Cell Res Ther. 2024; 15(1):176.
PMID: 38886861 PMC: 11184747. DOI: 10.1186/s13287-024-03800-6.
Management of the refractory vitiligo patient: current therapeutic strategies and future options.
Wang X, Wu W, Chen J, Li C, Li S Front Immunol. 2024; 14:1294919.
PMID: 38239366 PMC: 10794984. DOI: 10.3389/fimmu.2023.1294919.